Suchergebnisse - "Zhao, Ruiyue"

PubPharm (30)

1

Pathophysiology characterization of Alzheimer's disease in South China's aging population : for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)

enthalten in: Alzheimer's research & therapy | 2024

von Liu, Z. | Shi, D. | Cai, Y. | +23

2

Pathophysiology characterization of Alzheimer’s disease in South China’s aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)

enthalten in: Alzheimer's research & therapy | 2024

von Liu, Z. | Shi, D. | Cai, Y. | +23

3

First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093 : dosimetry and initial evaluation in prostate cancer patients

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Zhao, R. | Ke, M. | Lv, J. | +14

4

First-in-human study of D6-[18F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [18F]FP-(+)-DTBZ (AV-133)

enthalten in: ResearchSquare.com | 2024

von Zhao, R. | Chen, J. | Ye, T. | +11

5

Theranostic Agent Targeting Bone Metastasis : A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate

enthalten in: Journal of medicinal chemistry | 2024

von Jin, W. | Zhao, R. | Wang, R. | +6

6

Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform

enthalten in: EJNMMI radiopharmacy and chemistry | 2024

von Alexoff, D. | Choi, S. | Ploessl, K. | +4

7

Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform

enthalten in: EJNMMI radiopharmacy and chemistry | 2024

von Alexoff, D. | Choi, S. | Ploessl, K. | +4

8

18F-FAPI for Imaging Metastatic Perivascular Epithelioid Cell Neoplasm

enthalten in: Clinical nuclear medicine | 2024

von Zhang, J. | Ke, M. | Zhao, R. | +2

9

Determining the optimal pharmacokinetic modelling and simplified quantification method of [18F]AlF-P16-093 for patients with primary prostate cancer (PPCa)

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Zhao, R. | Xia, Z. | Ke, M. | +11

10

First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Zhao, R. | Ke, M. | Lv, J. | +14